OptiBiotix Health Plc is a life sciences company. The Company is engaged in the development of microbial strains, compounds, and formulations, which are used as active ingredients and supplements. It is focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. It is also developing its own range of consumer supplements and health products. Its areas of focus include obesity, cardiovascular health, and diabetes. Its products include SlimBiome, CholBiome, SweetBiotix, WellBiome, OptiBiotics and SlimBiome X3. SlimBiome offers a natural, scientifically supported, non-pharmaceutical approach to reducing hunger and cravings. CholBiome contains Lactobacillus plantarum LPLDL as the only active ingredient, focusing on healthy cholesterol maintenance and delivering tangible health benefits. SweetBiotix is a zero or low-calorie, prebiotic, and a smarter alternative to sugar and existing sweeteners.
Company Information
About this company
Key people
Stephen Patrick O'Hara
Chief Executive Officer, Executive Director
David Jonathan Blain
Finance Director, Executive Director, Company Secretary
Sofia Kolyda
Executive Director - Research and Development Director
Richard Colin Neil Davidson
Non-Executive Independent Chairman of the Board
Michael Sean Christie
Non-Executive Independent Director
Click to see more
Key facts
- Shares in issue103.30m
- EPICOPTI
- ISINGB00BP0RTP38
- LocationUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap£6.09m
- Employees5
- ExchangeLondon Stock Exchange (LON)
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.